| Previous Close | 0.2450 |
| Open | 0.3000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2450 - 0.3000 |
| 52 Week Range | 0.1100 - 2.7900 |
| Volume | 2,271 |
| Avg. Volume | 2,838 |
| Market Cap | 5.416M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0930 |
| Earnings Date | Jun 29, 2020 - Jun 30, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Despite the difficulties presented by the COVID-19 Pandemic, the Company continues to make progress on developing its proprietary Medical Robotic System. As AVRA CEO Barry Cohen explains, “The latest test results of AVRA’s Imaging and Detection System software designed to Detect, Identify, Diagnose, and Deliver an autonomous robotic surgical procedure continue to reinforce our confidence in our ability to develop an autonomous Medical Robotic System which should enable surgeons to sharply increase their productivity while also improving patient outcomes in the operating room of the future.”
AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an artificial intelligence company building a fully autonomous medical robotic system combining artificial intelligence, machine learning and proprietary software, today announces that its Chairman & CEO, Barry Cohen, has increased his stake in the company by approximately 5% by purchasing an additional 1,000,000 common shares of AVRA stock. The shares will be restricted.
ORLANDO, Fla., Feb. 03, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company building a fully autonomous.
ORLANDO, Fla., Jan. 17, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of.
AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company which is building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software, announced today it has appointed Dr. Vipul Patel to Chair its Medical Advisory Board and Dr. Eytan Pollak to Chair the Scientific Advisory Board, effective immediately.
The Company’s robot arm has already won approval in the EU and received the CE mark. The Company has begun implementing a quality and regulatory system that will serve as the foundation for US, Canadian, European, Australian, Japanese, and Brazilian market access for AVRA’s modern medical robotic system – a ground-breaking approach to medical robotics.
AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company developing a proprietary software coded system that uses artificial intelligence and machine learning capabilities for the purpose of creating the next generation of fully autonomous medical robotic systems, announced today that its Chief Strategy Officer, D. Nikhil Shah, delivered a presentation at this year’s Annual Meeting of the Society of Robotic Surgery. Barry Cohen, Chairman and Chief Executive Officer of the Company, commented, “I was extremely pleased that we were able to share the AVRA story at this year’s meeting of the Society of Robotic Surgery.